Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse Read more about Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
Natural History of Oro-pharyngeal Cancer Precursors Read more about Natural History of Oro-pharyngeal Cancer Precursors
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Read more about Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Connect® MM- The Multiple Myeloma Disease Registry Read more about Connect® MM- The Multiple Myeloma Disease Registry
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Read more about A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Read more about Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Read more about Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Read more about Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Read more about Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Read more about Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)